Skip to main content

Table 1 Characteristics of Filipino women by tertile distribution of energy-adjusted total BCAA intake in the FiLWHEL study

From: Dietary intakes of branched-chain amino acids and plasma lipid profiles among filipino women in Korea: the Filipino Women’s Diet and Health Study (FiLWHEL)

 

Tertile distribution of energy-adjusted total BCAA intake

Characteristics

Tertile 1

Tertile 2

Tertile 3

N

141

141

141

Age (years)

34.4 ± 8.1

35.7 ± 8.3

35.6 ± 7.4

 < 35 years

74 (52.5)

69 (48.9)

65 (46.1)

 ≥ 35 years

67 (47.5)

72 (51.1)

76 (53.9)

Length of stay (years)

7.8 ± 5.1

7.5 ± 4.6

7.7 ± 4.9

 ≤ 4 years

44 (31.2)

41 (29.1)

39 (27.6)

 5–9 years

49 (33.7)

59 (41.8)

62 (44.1)

 ≥ 10 years

48 (34.1)

41 (29.1)

40 (28.3)

Education

   

 Elementary and high school

44 (31.4)

42 (30.0)

44 (31.4)

 College education and above

97 (68.6)

99 (70.0)

97 (68.6)

Employment status (Yes)

71 (50.3)

76 (53.6)

84 (59.6)

Ever smoked (Yes)

12 (8.6)

9 (6.5)

15 (10.8)

Current alcohol use (Yes)

84 (59.5)

83 (58.9)

80 (56.7)

Vigorous physical activity (Yes)

31 (22.1)

22 (15.6)

26 (18.4)

History of diabetes* (Yes)

2 (1.4)

2 (1.4)

6 (4.3)

History of hypertension* (Yes)

11 (7.9)

9 (6.4)

9 (6.4)

BMI (kg/m2)

23.7 ± 3.8

23.4 ± 3.6

23.7 ± 4.3

 ≥ 25 kg/m2

48 (34.0)

42 (29.8)

38 (27.3)

Waist circumference (cm)

79.4 ± 8.8

79.0 ± 8.8

79.7 ± 10.4

 ≥ 80 cm

60 (42.6)

63 (44.7)

55 (39.0)

Total energy (kcal/d)

1844.4 ± 799.1

1558.1 ± 588.0

1810.1 ± 605.8

Dietary total BCAA intake (g/d)

4.4 ± 1.9

8.0 ± 0.8

12.5 ± 3.1

 Isoleucine intake (g/d)

1.1 ± 0.5

2.1 ± 0.2

3.2 ± 0.8

 Leucine intake (g/d)

1.9 ± 0.8

3.6 ± 0.4

5.6 ± 1.5

Valine intake (g/d)

1.3 ± 0.6

2.4 ± 0.3

3.7 ± 0.9

MDD-W score

6.0 ± 1.9

6.5 ± 1.7

6.8 ± 1.5

TG (mg/dl)

87.3 ± 44.1

90.2 ± 46.6

87.9 ± 51.6

 ≥ 150 mg/dl

13 (9.3)

14 (10.1)

14 (10.5)

TC (mg/dl)

177.6 ± 33.9

184.3 ± 34.2

177.1 ± 35.2

 ≥ 200 mg/dl

35 (25.0)

44 (31.9)

32 (23.9)

HDL-C (mg/dl)

57.7 ± 13.9

59.4 ± 13.8

57.0 ± 13.4

 ≤ 50 mg/dl

42 (30.0)

30 (21.7)

41 (30.6)

LDL-C (mg/dl)

102.4 ± 31.4

106.9 ± 29.7

102.5 ± 30.2

 ≥ 130 mg/dl

23 (16.4)

30 (21.7)

23 (17.2)

Dyslipidaemia (Yes)

76 (53.9)

67 (47.5)

65 (46.1)

  1. mean ± SD for continuous variables and n (%) for categorical variables
  2. *Self-reported clinical diagnosis or current use of medication; BMI: body mass index; MDD-W: minimum dietary diversity for women; TG: triglycerides; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol
  3. Amino acid intake was adjusted for energy intake using the residual method
  4. Dyslipidemia was defined as one of the following conditions; a previous diagnosis of elevated lipid profiles, current use of statins or lipid-lowering medications, TG ≥ 150 mg/dl, TC ≥ 200 mg/dl, HDL-C < 50 mg/dl or LDL-C ≥ 130 mg/dl according to the NCEP-ATP (III) guidelines.